المـعـهـد

تعليمات المرضى
الأبحاث

اصدارات

الذباب المنزلى

الطفيليات

التثقيف الصحى

 

Dear Doctor:

 

Peginterferon is now available in National Hepatology and Tropical Medicine Research Institute (NHTMRI) in low prices.

If one of your patients is in need of it you can refer him to (NHTMRI)

 

Patients will be chosen according to the following criteria

 

Inclusion Criteria

Yes

A. Male or Female  18  - 60 y  

 

B. WBC > 4,000/mm3

 

C. Neutophil Count > 2,000/mm3

 

D. platelets > 75,000/mm3

 

E. prothrombin Time < 2 Sec Above ULN

 

F. Indirect Bilirubin 0.3mg/dl within 20% ULN

 

G. Direct  Bilirubin 0.8mg or within 20% ULN

 

H. Fasting Blood Sugar 115 mg or within 20% ULN

 

I. Albumin > 3.5 ml/dl

 

J. Serum Creatinine  WNL

 

K. TSH   WNL

 

L. HBsAg Negative

 

M. ANA < 1:160

 

N. Positive Anti-HCV and HCV RNA

 

O. If Diabetes, AIC < 8.5%

 

P. Alpha Feto-protein < 100 IU/ml

 

Q. If Alpha Feto-protein is abnormal > 100 IU/ml but

     C.T is normal

 

R. female patients practicing adequate contraception

 

S. Male patients  practicing adequate contraception

 

T. Signed written informed consent

 

 

 

 

 

 

 

 

 

 

 

 

 

ULN = Upper Limit Normal

WNL = Within Normal Limit

 

Yes

Exclusion Criteria

 

A. Exclusion of any other cause of liver disease other than H C V (by liver biopsy)

 

B. Exclusion of co-infection with HBV

 

C. Exclusion of hemochromatosis (by liver Biopsy)

 

D. Exclusion of alpha 1-antitrypsin deficiency (by liver biopsy )

 

E. Exclusion of Wilson's disease (by liver biopsy)

 

F. Exclusion of autoimmune disease (ANA)

 

G. Exclusion of alcoholic liver disease

 

H. Exclusion of decompensated liver disease

 

I. Exclusion of hypersensitivity to interferon or Ribavirin

 

J. Exclusion of any other condition which in the judgment of investigator disqualifies the patient from entering the protocol

 

K. Exclusion of pregnancy or breast feeding

 

L. Exclusion of poorly controlled diabetes

 

M. Exclusion of clinically significant retinal abnormalities

 

N. Exclusion of obesity -induced liver disease 

 

O. Exclusion of drug- related liver disease

 

P. Exclusion of CNS trauma which requires medication

 

Q. Exclusion of active seizures which requires medication

 

R. Exclusion of ischemic cardiovascular disease within the last 6 months

 

S. Exclusion of immunologically mediated disease (ulcerative colitis, Crohn,s disease .ITP. SLE autoimmune hemolytic anemia, scleroderma , severe psoriasis and rheumatoid arthritis)

 

T. Exclusion of patients with organ transplants

 

 U. Exclusion of substance abuse (alcohol >80gm/d) iv drugs and inhaled drugs

 

V. If past history of substance abuse abstention for      the post 12 months?

 

W. Exclusion of amantadine ,flumantadine, steroids,    siercide, and/or immunosuppressive drugs

 

X. Exclusion of sever pre- existing psychiatric conditions

 

Y. Exclusion of any history of manic element associated to prior psychiatric history

 

It is better if the patient do the following

Pre-Enrollment test

Test

Glucose

Creatinine

Albumin

Alk  Phos

AST

ALT

Total Bili

WBC (x1000)

Haemoglobin

Platelets

Prothrombin

Urine Analysis

Pregnancy Test

HbsAg

Anti-HCV

ANA Titer

TSH

HCV RNA

AFP

ECG ( Men over 40, Women over 50 )

Funds  Examination

Anti Schisto Ab

Liver Ultrasound

Liver Biopsy

  • During last month

  • During last 3 months

  • During last year

For more information:   hepc@nhtmri.org

 

 

Copyrights@ 2005 NHTMRI All rights are reserved.

Powered by DOT IT